Table 2.

Multivariable analysis in the training cohort.

Variables in the final model	HR	95%CI	P
Overall survival
HBV infection, yes vs. no	1.62	0.83–3.16	0.161
MVI, yes vs. no	2.02	1.28–3.17	0.002
IS-TB type
Type II vs. type I and IV	3.07	1.83–5.13	< 0.001
Type III vs. type I and IV	0.50	0.29–0.87	0.013
Disease-free survival
MVI, yes vs. no	2.01	1.42–2.85	< 0.001
AFP level, ≥400 ng/ml vs. < 400 ng/ml	1.56	1.12–2.19	0.009
Tumor differentiation, grade III-IV vs. grade I-II	1.43	1.01–2.03	0.045
IS-TB type
Type II vs. type I and IV	2.06	1.38–3.07	< 0.001
Type III vs. type I and IV	0.60	0.40–0.91	0.015

HBV, hepatitis b virus; MVI, microvascular invasion; ALBI, albumin-bilirubin; AFP, alpha fetoprotein; HR, hazard ratio; CI, confidence interval.